Literature DB >> 2334253

Peripheral vs central squamous cell carcinoma of the lung. A comparison of clinical features, histopathology, and survival.

J F Tomashefski1, A F Connors, E S Rosenthal, I L Hsiue.   

Abstract

We reviewed the clinical features and histopathologic findings of 21 peripheral pulmonary squamous cell carcinomas (SCC) resected at our institution between 1961 and 1981 and compared them with 19 central SCCs. Histologic features were scored semiquantitatively from 0 to 3+. Peripheral SCC represented 16% of all resected SCCs. The proportion of patients with multiple symptoms was lower and survival during the 5 years after surgery was better in the peripheral group. Tumor size, mitoses per high-power field (2.4 +/- 0.3 vs 4.1 +/- 0.6 [SEM]), prevalence of lymphatic invasion (19% vs 58%), and lymph node metastases (5% vs 37%) were lower, while chest wall invasion was more frequent (25% vs 0) for peripheral SCCs. Peripheral tumors also had more intense (2 or 3+) lymphoplasmacytic (86% vs 47%) and desmoplastic (95% vs 68%) reactions. Cox regression analysis did not support a significant relationship between tumor location and survival. We conclude that, compared with the central SCC, peripheral SCC is associated with fewer symptoms at presentation and better survival. Morphologically, peripheral SCCs are smaller, have fewer mitoses, less prevalent lymphatic invasion, and a more intense stromal reaction. Improved survival in patients with peripheral SCC may be due to a more favorable stage at the time of initial treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2334253

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  Clinicopathological features of small-sized peripheral squamous cell lung cancer.

Authors:  Takayuki Kosaka; Kimihiro Shimizu; Seshiru Nakazawa; Misaki Iijima; Yoichi Ohtaki; Yoko Azuma; Kai Obayashi; Toshiteru Nagashima; Toshiki Yajima; Akira Mogi; Hiroyuki Kuwano; Ken Shirabe
Journal:  Mol Clin Oncol       Date:  2019-11-18

3.  EBUS in optimizing non-small cell lung cancer diagnosis and treatment.

Authors:  Antonia Haranguş; Ioana Berindan-Neagoe; Lăcrămioara Toma; Ioan Şimon; Ovidiu Pop; Mărioara Şimon
Journal:  Med Pharm Rep       Date:  2021-04-29

4.  The changing anatomic position of squamous cell carcinoma of the lung - a new conundrum.

Authors:  William Krimsky; Nargiz Muganlinskaya; Saiyad Sarkar; Manasa Vulchi; Pujan Patel; Suman Rao; Joel Hammer; Ruth Evans; Muhammad Qureshi; Daniel Harley
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

5.  Alveolar architectures preserved in cancer tissues may be potential pitfalls for diagnosis and histological subtyping of lung cancer: Three case reports.

Authors:  Xiaoxi Fan; Xiupeng Zhang; Enhua Wang; Chuifeng Fan
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.